UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis

Calcified tissue international, 2024-04, Vol.114 (4), p.386-396

2024

Volltextzugriff (PDF)

Hydraulic Fracture Propagation in Rock Mass with XFEM

Soil mechanics and foundation engineering, 2023-11, Vol.60 (5), p.436-443

2023

Volltextzugriff (PDF)

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Annals of oncology, 2018-11, Vol.29, p.ix157-ix157

2018

Volltextzugriff (PDF)

Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis

British journal of dermatology (1951), 2020-05, Vol.182 (5), p.1309-1310

2020

Volltextzugriff (PDF)

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

Annals of oncology, 2018-10, Vol.29, p.viii604-viii604

2018

Volltextzugriff (PDF)

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Annals of oncology, 2017-10, Vol.28 (10), p.2443

2017

Volltextzugriff (PDF)

ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test

Annals of oncology, 2018-11, Vol.29, p.ix143-ix143

2018

Volltextzugriff (PDF)

Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii503-viii504

2018

Volltextzugriff (PDF)

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

Leukemia, 2008-01, Vol.22 (1), p.179-185

2008

Volltextzugriff (PDF)

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

Annals of oncology, 2017-11, Vol.28 (11), p.2698-2706

2017

Volltextzugriff (PDF)

CSR1 induces cell death through inactivation of CPSF3

Oncogene, 2009-01, Vol.28 (1), p.41-51

2009

Volltextzugriff (PDF)

Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7

Cancer gene therapy, 2010-10, Vol.17 (10), p.694-699

2010

Volltextzugriff (PDF)

Prognostic factors for ovarian metastases from primary gastric cancer

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.825-832

2008

Volltextzugriff (PDF)

Phase I study of safety and pharmacokinetics for CT-707 in ALK-positive advanced non-small cell lung cancer

Annals of oncology, 2017-11, Vol.28, p.x132-x132

2017

Volltextzugriff (PDF)

LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer

European review for medical and pharmacological sciences, 2019-12, Vol.23 (24), p.10842

2019

Volltextzugriff (PDF)

Humanized recombinant endostatin combined with vinorelbine plus cisplatin followed by maintenance therapy with humanized recombinant endostatin in advanced non-small cell lung cancer: A multicentre, double-blind, randomised phase 3 trial

Annals of oncology, 2017-11, Vol.28, p.x124-x124

2017

Volltextzugriff (PDF)

On microstructure and fatigue characterisation of cast iron alloyed with PTA deposits

Surface engineering, 2012-03, Vol.28 (2), p.113-121

2012

Volltextzugriff (PDF)

Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors

Zhōnghuá zhŏngliú zázhì, 2018-07, Vol.40 (7), p.490

2018

Volltextzugriff (PDF)

EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)

Annals of oncology, 2017-11, Vol.28, p.x127-x128

2017

Volltextzugriff (PDF)

EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel in patients with non-small-cell lung cancer who had received a platinum-based treatment

Annals of oncology, 2016-10, Vol.27, p.vi421-vi421

2016

Volltextzugriff (PDF)

The development of biosimilars in oncology

Zhōnghuá zhŏngliú zázhì, 2017-10, Vol.39 (10), p.721

2017

Volltextzugriff (PDF)

Efficacy and safety of first-line gefitinib treatment in metastatic lung adenocarcinoma patients with sensitizing EGFR mutation determined by ddPCR in plasma cell-free DNA (BENEFIT trial)

Annals of oncology, 2016-10, Vol.27, p.vi448-vi448

2016

Volltextzugriff (PDF)

First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with EGFR mutation (CONVINCE)

Annals of oncology, 2016-10, Vol.27, p.vi425-vi425

2016

Volltextzugriff (PDF)

Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma

Zhōnghuá zhŏngliú zázhì, 2020-03, Vol.42 (3), p.234

2020

Volltextzugriff (PDF)

Surgical treatment of port-site metastases after laparoscopic radical resection of gastric cancer

Zhong hua yi xue za zhi, 2019-08, Vol.99 (32), p.2497-2500

2019

Volltextzugriff (PDF)

1 – 25 von 12.310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.553)
Mit Volltextzugriff
(10.481)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(8.046)
Physical Sciences
(3.592)
Life Sciences & Biomedicine
(3.113)
Physics
(3.050)
Technology
(2.664)
Humans
(2.037)
Animals
(1.127)
Male
(1.085)
Female
(1.049)
Engineering
(1.002)
Biological And Medical Sciences
(998)
Exact Sciences And Technology
(963)
Materials Science
(917)
Physics Of Elementary Particles And Fields
(867)
Physics, Applied
(748)
Chemistry
(743)
Computer Science
(733)
Physics And Astronomy
(716)
Elementary Particles
(687)
Medical Sciences
(685)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(5.213)
Ingenta
(4.109)
MEDLINE
(3.007)
Elsevier ScienceDirect Journals Complete
(2.151)
Publisher or Other Site
(1.813)
Journals@Ovid Full Text
(1.765)
Springer Nature
(1.730)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.612)
IngentaConnect Journals
(1.311)
APS: American Physical Society E-Journals (Physics)
(1.186)
Wiley Online Library Journals
(845)
PROLA - Physical Review Online Archive
(728)
IEEE Xplore
(660)
Wiley Online Library Full Collection 2018
(639)
Springer Book Series
(437)
Taylor & Francis Journals
(399)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(387)
Nature Journals
(366)
Ebook Central Perpetual and DDA
(308)
eBooks on EBSCOhost
(304)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis

Hydraulic Fracture Propagation in Rock Mass with XFEM

AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)

Autoimmune disease development before and after cutaneous lupus erythematosus diagnosis

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

ASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test

Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

CSR1 induces cell death through inactivation of CPSF3

Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7

Prognostic factors for ovarian metastases from primary gastric cancer

Phase I study of safety and pharmacokinetics for CT-707 in ALK-positive advanced non-small cell lung cancer

LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer

Humanized recombinant endostatin combined with vinorelbine plus cisplatin followed by maintenance therapy with humanized recombinant endostatin in advanced non-small cell lung cancer: A multicentre, double-blind, randomised phase 3 trial

On microstructure and fatigue characterisation of cast iron alloyed with PTA deposits

Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors

EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel (DOC) in patients with non-small cell lung cancer (NSCLC) who had received a platinum-based treatment: Results from patient-reported outcomes (PROs)

EAST-LC: Randomized controlled phase III trial of S-1 versus docetaxel in patients with non-small-cell lung cancer who had received a platinum-based treatment

The development of biosimilars in oncology

Efficacy and safety of first-line gefitinib treatment in metastatic lung adenocarcinoma patients with sensitizing EGFR mutation determined by ddPCR in plasma cell-free DNA (BENEFIT trial)

First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with EGFR mutation (CONVINCE)

Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma

Surgical treatment of port-site metastases after laparoscopic radical resection of gastric cancer

Suchergebnisse filtern